398 related articles for article (PubMed ID: 16723096)
1. In vitro characteristics of poly(lactic-co-glycolic acid) microspheres incorporating gelatin particles loading basic fibroblast growth factor.
Li SH; Cai SX; Liu B; Ma KW; Wang ZP; Li XK
Acta Pharmacol Sin; 2006 Jun; 27(6):754-9. PubMed ID: 16723096
[TBL] [Abstract][Full Text] [Related]
2. A novel biodegradable system based on gelatin nanoparticles and poly(lactic-co-glycolic acid) microspheres for protein and peptide drug delivery.
Li JK; Wang N; Wu XS
J Pharm Sci; 1997 Aug; 86(8):891-5. PubMed ID: 9269865
[TBL] [Abstract][Full Text] [Related]
3. A novel trans-lymphatic drug delivery system: implantable gelatin sponge impregnated with PLGA-paclitaxel microspheres.
Liu J; Meisner D; Kwong E; Wu XY; Johnston MR
Biomaterials; 2007 Jul; 28(21):3236-44. PubMed ID: 17434581
[TBL] [Abstract][Full Text] [Related]
4. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres.
Perets A; Baruch Y; Weisbuch F; Shoshany G; Neufeld G; Cohen S
J Biomed Mater Res A; 2003 Jun; 65(4):489-97. PubMed ID: 12761840
[TBL] [Abstract][Full Text] [Related]
5. Stabilization and encapsulation of a staphylokinase variant (K35R) into poly(lactic-co-glycolic acid) microspheres.
He JT; Su HB; Li GP; Tao XM; Mo W; Song HY
Int J Pharm; 2006 Feb; 309(1-2):101-8. PubMed ID: 16413979
[TBL] [Abstract][Full Text] [Related]
6. A protein delivery system: biodegradable alginate-chitosan-poly(lactic-co-glycolic acid) composite microspheres.
Zheng CH; Gao JQ; Zhang YP; Liang WQ
Biochem Biophys Res Commun; 2004 Oct; 323(4):1321-7. PubMed ID: 15451441
[TBL] [Abstract][Full Text] [Related]
7. Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique.
Karal-Yılmaz O; Serhatlı M; Baysal K; Baysal BM
J Microencapsul; 2011; 28(1):46-54. PubMed ID: 21171816
[TBL] [Abstract][Full Text] [Related]
8. Long-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly(L-lactide-co-glycolide) nanospheres and fibrin gel.
Jeon O; Kang SW; Lim HW; Hyung Chung J; Kim BS
Biomaterials; 2006 Mar; 27(8):1598-607. PubMed ID: 16146647
[TBL] [Abstract][Full Text] [Related]
9. In vitro stress effect on degradation and drug release behaviors of basic fibroblast growth factor--poly(lactic-co-glycolic-acid) microsphere.
Xiong Y; Yu Z; Lang Y; Hu J; Li H; Yan Y; Tu C; Yang T; Song Y; Duan H; Pei F
Drug Des Devel Ther; 2016; 10():431-40. PubMed ID: 26869764
[TBL] [Abstract][Full Text] [Related]
10. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
[TBL] [Abstract][Full Text] [Related]
11. Bupivacaine-loaded biodegradable poly(lactic-co-glycolic) acid microspheres I. Optimization of the drug incorporation into the polymer matrix and modelling of drug release.
Zhang H; Lu Y; Zhang G; Gao S; Sun D; Zhong Y
Int J Pharm; 2008 Mar; 351(1-2):244-9. PubMed ID: 18024022
[TBL] [Abstract][Full Text] [Related]
12. Effect of mean diameter and polydispersity of PLG microspheres on drug release: experiment and theory.
Berchane NS; Carson KH; Rice-Ficht AC; Andrews MJ
Int J Pharm; 2007 Jun; 337(1-2):118-26. PubMed ID: 17289316
[TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of PLGA particles for subcutaneous controlled drug release by membrane emulsification.
Gasparini G; Kosvintsev SR; Stillwell MT; Holdich RG
Colloids Surf B Biointerfaces; 2008 Feb; 61(2):199-207. PubMed ID: 17919891
[TBL] [Abstract][Full Text] [Related]
14. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of PLGA microspheres containing a staphylokinase variant (K35R).
He JT; Tao XM; Mo W; Song HY
Yao Xue Xue Bao; 2006 Jan; 41(1):12-8. PubMed ID: 16683521
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characteristics of interferon-alpha poly(lactic-co-glycolic acid) microspheres.
Yang F; Song FL; Pan YF; Wang ZY; Yang YQ; Zhao YM; Liang SZ; Zhang YM
J Microencapsul; 2010; 27(2):133-41. PubMed ID: 20121486
[TBL] [Abstract][Full Text] [Related]
17. Versatility of biodegradable poly(D,L-lactic-co-glycolic acid) microspheres for plasmid DNA delivery.
Díez S; Tros de Ilarduya C
Eur J Pharm Biopharm; 2006 Jun; 63(2):188-97. PubMed ID: 16697172
[TBL] [Abstract][Full Text] [Related]
18. Controlled release of bioactive doxorubicin from microspheres embedded within gelatin scaffolds.
Defail AJ; Edington HD; Matthews S; Lee WC; Marra KG
J Biomed Mater Res A; 2006 Dec; 79(4):954-62. PubMed ID: 16941588
[TBL] [Abstract][Full Text] [Related]
19. Biodegradable polymeric microspheres with "open/closed" pores for sustained release of human growth hormone.
Kim HK; Chung HJ; Park TG
J Control Release; 2006 May; 112(2):167-74. PubMed ID: 16542746
[TBL] [Abstract][Full Text] [Related]
20. Heparin-immobilized biodegradable scaffolds for local and sustained release of angiogenic growth factor.
Yoon JJ; Chung HJ; Lee HJ; Park TG
J Biomed Mater Res A; 2006 Dec; 79(4):934-42. PubMed ID: 16941589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
